MRX vs SNEX: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
SNEX is the larger of the two ($6.80B market cap): the incumbent the market prices for continued execution (11.93x forward earnings, beta 0.63). MRX is the smaller challenger ($4.98B), cheaper on forward earnings (9.59x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
MRX vs SNEX: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | MRX | SNEX | What it tells you |
|---|---|---|---|
| Market cap | $4.98B | $6.80B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 9.59 | 11.93 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 12.44 | 18.68 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 0.07 | 0.63 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 78% of range | 34% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 3.39 | 2.38 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: MRX is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how MRX and SNEX affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. MRX and SNEX share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined MRX and SNEX exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Marex Group plc (MRX) do?
Marex Group Limited (the company was Marex Group plc until its redomiciling) operates a diversified global financial services platform that sits between clients and the world's energy, metals, and commodities markets. Its main activities are clearing (handling post-trade processing and holding client balances), agency and execution (matching buyers and sellers and providing price discovery), market making, and hedging and investment solutions such as structured notes. The company also runs technology platforms including Neon (trading, risk, and data) and has grown rapidly through both organic expansion and acquisitions since incorporating in 2005.
What does StoneX Group (SNEX) do?
StoneX Group Inc. is a New York-headquartered financial-services firm that stands as a middleman between clients and the world's financial and commodity markets. It serves more than 54,000 commercial, institutional, and global-payments clients plus over 400,000 retail accounts across roughly 80 offices on five continents, organizing its work into four segments: Commercial (agricultural, energy, and metals hedging), Institutional (securities, futures, FX, and prime services), Retail (self-directed trading brands), and Global Payments (cross-border money movement into hard-to-reach currencies). Because much of what StoneX does is regulated brokerage, clearing, and market-making, the company operates as a holding company over many licensed subsidiaries. A defining recent move was the roughly $900 million acquisition of futures broker R.J. O'Brien, which closed on July 31, 2025 and made StoneX the largest non-bank futures commission merchant in the United States, adding tens of thousands of clients and billions in client float.
MRX vs SNEX: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- MRX drivers: Volatility-driven trading volumes; Clearing scale and client balances.
- SNEX drivers: Scale from the R.J. O'Brien deal; Interest income on client float.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Marex's earnings are cyclical and depend heavily on client trading volumes and market volatility, which can fall sharply in quiet markets and compress commissions. For SNEX, stoneX operates in a low-margin, capital-intensive, and highly regulated industry where a single operational, credit, or compliance failure at any of its many subsidiaries can be costly.
MRX or SNEX: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick MRX if you believe its drivers more; SNEX if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the MRX and SNEX guides.
MRX vs SNEX: the full fundamentals
MRX. Marex has beaten EPS estimates four quarters running, most recently $1.64 versus ~$1.36 for Q2 2026, and the stock is up ~87% in 2026 to ~$70.88. It still trades at about 14 times trailing and 11 times forward earnings, because consensus expects 2027 EPS growth of only ~8% after a ~55% jump in 2026. The quarterly dividend of ~$0.16 per share ($0.64 a year) yields under 1% at the current price, with a payout ratio near 12%.
SNEX. StoneX has grown earnings sharply in fiscal 2026 as the RJO acquisition, client float and active markets fed through, and every quarter in the past year beat estimates. Note the revenue distinction: the firm reports well over $100 billion of gross transactional revenue that is largely pass-through cost, so net income and operating revenues are the more meaningful figures, and margins on the gross line (~0.3% net) say little. At ~$57.74, after two 3-for-2 splits in 2026, the stock trades around 19 times trailing and 12 times forward earnings, cheaper than earlier in the year after a ~23% three-month pullback.
Headline figures (approximate, October 2026): MRX shows revenue (ttm) ~$3.5B, revenue growth (latest quarter, yoy) ~32%, net income (ttm) ~$376M, eps (trailing / forward) ~$4.95 / ~$6.65; SNEX shows gross revenue (ttm) ~$155.8B, up ~15.2% YoY in the latest quarter (mostly pass-through physical commodity sales), net income (ttm) ~$510M (vs ~$306M in FY2025), latest quarter (june 2026) Net income ~$128M; EPS $1.04 vs ~$0.82 consensus, eps (trailing / fy2026 consensus) ~$3.02 / ~$4.63 (post-split basis).
The bottom line: MRX vs SNEX
MRX and SNEX are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined MRX and SNEX exposure against your real portfolio. It is not an investment adviser.
Wondering how MRX or SNEX fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Marex Group plc
Ask Walnut's AI anything about MRX and see how it fits what you own.
FAQ
What is the difference between MRX and SNEX?
+
Marex Group Limited (the company was Marex Group plc until its redomiciling) operates a diversified global financial services platform that sits between clients and the world's energy, metals, and commodities markets. StoneX Group Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is MRX or SNEX the better stock?
+
Neither is universally better. SNEX is the larger incumbent; MRX is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, MRX or SNEX?
+
On forward P/E (as of November 2026), MRX trades at 9.59x and SNEX at 11.93x, so MRX is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both MRX and SNEX?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of MRX vs SNEX?
+
MRX: Marex's earnings are cyclical and depend heavily on client trading volumes and market volatility, which can fall sharply in quiet markets and compress commissions. A meaningful share of profit comes from net interest income on client balances, so lower interest rates would reduce a high-margin revenue stream. The commission and clearing businesses carry counterparty, credit, and operational risk, and a large default or a risk-management failure could cause outsized losses. Rapid acquisition-led growth adds integration and execution risk, and the firm operates in a heavily regulated, capital-intensive industry across multiple jurisdictions. The redomiciling to Marex Group Limited, board changes announced in October 2026, and ongoing structural changes add complexity that investors weigh alongside the growth. After an ~87% gain in 2026 (and ~137% over one year), the share price also embeds more of the good news than it did at the July update, and the 52-week range of ~$30 to ~$79 shows how sharply it can move. SNEX: StoneX operates in a low-margin, capital-intensive, and highly regulated industry where a single operational, credit, or compliance failure at any of its many subsidiaries can be costly. Earnings are cyclical and depend on volatility, trading volumes, and interest rates, so a calm market or falling rates can pressure results. The acquisition-heavy strategy carries integration and leverage risk, and the RJO deal added debt and execution demands. As an intermediary the firm is exposed to counterparty and client-credit risk, and its very large gross-revenue figures can obscure the thinner underlying economics, which makes the stock prone to sharp swings, as its wide 52-week trading range shows. The stock fell ~23% over the three months to October 16, 2026 and ~14% in the past month, and a string of insider share sales was disclosed in SEC filings in late September and October 2026. Fiscal fourth-quarter results are expected around November 23, 2026, with consensus EPS of ~$0.92, below the ~$1.04 earned in the June quarter.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell MRX or SNEX; figures are approximate and dated (as of November 2026). Verify current data before investing.